By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company China Biotech Services Holdings Limited

China Biotech Services Holdings Limited (8037.HK)

HKSE Currency in HKD
$1.03
-$0.03
-2.83%
Last Update: 1 Sept 2025, 05:11
$1.01B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.25 - $1.33
52 Week Range

8037.HK Stock Price Chart

Explore China Biotech Services Holdings Limited interactive price chart. Choose custom timeframes to analyze 8037.HK price movements and trends.

8037.HK Company Profile

Discover essential business fundamentals and corporate details for China Biotech Services Holdings Limited (8037.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

17 Jun 2004

Employees

141.00

CEO

Xiaolin Liu

Description

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.

8037.HK Financial Timeline

Browse a chronological timeline of China Biotech Services Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 5 Jun 2025

Earnings released on 28 Mar 2025

EPS came in at -$0.06 , while revenue for the quarter reached $19.03M .

Earnings released on 14 Nov 2024

EPS came in at -$0.06 , while revenue for the quarter reached $19.03M .

Earnings released on 27 Aug 2024

EPS came in at -$0.04 , while revenue for the quarter reached $16.22M .

Earnings released on 5 Jun 2024

EPS came in at -$0.04 , while revenue for the quarter reached $16.22M .

Earnings released on 29 Mar 2024

EPS came in at -$0.07 , while revenue for the quarter reached $29.63M .

Earnings released on 13 Nov 2023

EPS came in at -$0.04 , while revenue for the quarter reached $18.36M .

Earnings released on 12 Aug 2023

EPS came in at -$0.02 , while revenue for the quarter reached $51.80M .

Dividend declared on 19 May 2023

A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 15 Jun 2023.

Earnings released on 12 May 2023

EPS came in at -$0.01 , while revenue for the quarter reached $130.56M .

Earnings released on 25 Mar 2023

EPS came in at $0.25 , while revenue for the quarter reached $575.78M .

Earnings released on 15 Nov 2022

EPS came in at $0.27 , while revenue for the quarter reached $588.84M .

Earnings released on 13 Aug 2022

EPS came in at $0.04 , while revenue for the quarter reached $384.09M .

Earnings released on 30 Jun 2022

EPS came in at $0.10 , while revenue for the quarter reached $302.82M .

Earnings released on 29 Mar 2022

EPS came in at -$0.01 , while revenue for the quarter reached $118.36M .

Earnings released on 12 Nov 2021

EPS came in at $0.00 , while revenue for the quarter reached $131.24M .

Earnings released on 14 Aug 2021

EPS came in at $0.02 , while revenue for the quarter reached $219.99M .

Earnings released on 12 May 2021

EPS came in at $0.00 , while revenue for the quarter reached $154.17M .

Earnings released on 24 Mar 2021

EPS came in at $0.01 , while revenue for the quarter reached $108.76M .

Earnings released on 11 Nov 2020

EPS came in at $0.06 , while revenue for the quarter reached $515.73M .

8037.HK Stock Performance

Access detailed 8037.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run